MXPA05013943A - Tableta que comprende fluvastatina y carmelosa-calcio. - Google Patents

Tableta que comprende fluvastatina y carmelosa-calcio.

Info

Publication number
MXPA05013943A
MXPA05013943A MXPA05013943A MXPA05013943A MXPA05013943A MX PA05013943 A MXPA05013943 A MX PA05013943A MX PA05013943 A MXPA05013943 A MX PA05013943A MX PA05013943 A MXPA05013943 A MX PA05013943A MX PA05013943 A MXPA05013943 A MX PA05013943A
Authority
MX
Mexico
Prior art keywords
fluvastatin
tablet
carmellose calcium
containing tablet
carmellose
Prior art date
Application number
MXPA05013943A
Other languages
English (en)
Inventor
Kenichi Kitaoka
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA05013943A publication Critical patent/MXPA05013943A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a una tableta que contiene fluvastatina, en particular a una tableta que contiene fluvastatina la cual tiene una excelente propiedad de desintegracion y una buena biodisponibilidad. La tableta que contiene fluvastatina se caracteriza porque comprende carmelosa-calcio como un agente de desintegracion.
MXPA05013943A 2003-06-25 2004-06-24 Tableta que comprende fluvastatina y carmelosa-calcio. MXPA05013943A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003181349 2003-06-25
PCT/EP2004/006865 WO2005000276A1 (en) 2003-06-25 2004-06-24 Tablet comprising fluvastatin and carmellose calcium

Publications (1)

Publication Number Publication Date
MXPA05013943A true MXPA05013943A (es) 2006-02-24

Family

ID=33549526

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05013943A MXPA05013943A (es) 2003-06-25 2004-06-24 Tableta que comprende fluvastatina y carmelosa-calcio.

Country Status (21)

Country Link
US (1) US20090117181A1 (es)
EP (1) EP1641440B1 (es)
KR (1) KR20060030480A (es)
CN (1) CN1809342A (es)
AT (1) ATE471713T1 (es)
AU (1) AU2004251439B2 (es)
BR (1) BRPI0411855A (es)
CA (1) CA2529447A1 (es)
CO (1) CO5650224A2 (es)
DE (1) DE602004027808D1 (es)
EC (1) ECSP056238A (es)
IL (1) IL172531A0 (es)
IS (1) IS8249A (es)
MA (1) MA27889A1 (es)
MX (1) MXPA05013943A (es)
NO (1) NO20060261L (es)
NZ (1) NZ544119A (es)
RU (1) RU2361582C2 (es)
TN (1) TNSN05330A1 (es)
WO (1) WO2005000276A1 (es)
ZA (1) ZA200509930B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009527577A (ja) * 2006-02-24 2009-07-30 テバ ファーマシューティカル インダストリーズ リミティド フルバスタチンナトリウム医薬組成物
CN103200930A (zh) * 2010-10-12 2013-07-10 拜耳知识产权有限责任公司 非淀粉基软咀嚼品
WO2012141160A1 (ja) 2011-04-12 2012-10-18 沢井製薬株式会社 ピタバスタチン含有製剤及びその製造方法
CN102309452B (zh) * 2011-09-14 2013-01-23 海南美大制药有限公司 氟伐他汀钠脂质体固体制剂
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物
CN104095850B (zh) * 2013-04-03 2019-04-05 深圳信立泰药业股份有限公司 一种稳定的匹伐他汀钙药物组合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
GB9703388D0 (en) * 1997-02-18 1997-04-09 Sandoz Yakuhin K K Tokyo Sykk Organic compounds
AR035016A1 (es) * 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
US20030060488A1 (en) * 2000-02-10 2003-03-27 Yasuo Sugiyama Drug comprising combination
US20020025952A1 (en) * 2000-07-06 2002-02-28 American Home Products Corporation Combinations of statins, estrogens and estrogenic agents
AU2001294192A1 (en) * 2000-10-06 2002-04-22 Takeda Chemical Industries Ltd. Solid preparations

Also Published As

Publication number Publication date
DE602004027808D1 (de) 2010-08-05
RU2006101889A (ru) 2007-08-10
ZA200509930B (en) 2007-01-31
NO20060261L (no) 2006-01-18
US20090117181A1 (en) 2009-05-07
CA2529447A1 (en) 2005-01-06
IS8249A (is) 2006-01-20
RU2361582C2 (ru) 2009-07-20
ECSP056238A (es) 2006-04-19
BRPI0411855A (pt) 2006-08-29
TNSN05330A1 (en) 2007-07-10
EP1641440A1 (en) 2006-04-05
MA27889A1 (fr) 2006-05-02
KR20060030480A (ko) 2006-04-10
EP1641440B1 (en) 2010-06-23
NZ544119A (en) 2008-04-30
ATE471713T1 (de) 2010-07-15
AU2004251439B2 (en) 2008-09-11
CN1809342A (zh) 2006-07-26
CO5650224A2 (es) 2006-06-30
IL172531A0 (en) 2006-04-10
WO2005000276A1 (en) 2005-01-06
AU2004251439A1 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
GB0204771D0 (en) Fast disintegrating tablets
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
ZA200500432B (en) Sustained-release tablet comprising reboxetine
TNSN05330A1 (en) Tablet comprising fluvastatin and carmellose calcium
IL159088A0 (en) Hard bouillon tablet
EG23361A (en) High utility tissue.
MY133322A (en) Storage stable tablets of fosinopril sodium
ZA200206403B (en) Spice crusher.
ZA200408787B (en) Pharmaceutical combination.
TW200500081A (en) Novel rotaviruses and use thereof
TW547141U (en) Kitchen remainder processor
GB0227756D0 (en) P.H. tablet
AU2717P (en) LadyO Grevillea victoriae x Grevillea rhyolitica
GB2392981B (en) Barometer
ZA200203646B (en) Product interchange.
TW551556U (en) Keyboard having pedestal
UA11029U (uk) Композиція для лікарського засобу
AU148728S (en) Tablet
AU148729S (en) Tablet
AU303058S (en) Hat
PL113563U1 (en) Kitchen lamp
GB0210060D0 (en) Improvements in the production of bales
GB0219744D0 (en) Tablet compositions
ZA200409837B (en) Device to prevent rocking of tables.